Filtered By:
Infectious Disease: Epidemics
Therapy: Chemotherapy

This page shows you your search results in order of relevance.

Order by Relevance | Date

Total 102 results found since Jan 2013.

Would Legalizing Medical Marijuana Help Curb The Opioid Epidemic?
This study and a few others provided some evidence regarding the potential positive benefits of legalizing marijuana to reduce opioid use and abuse, but they are still preliminary,” she said in an email. Dr. Esther Choo, a professor of emergency medicine at Oregon Health and Science University in Portland, was intrigued by the study’s suggestion that access to cannabis might reduce opioid misuse. “It is becoming increasingly clear that battling the opioid epidemic will require a multi-pronged approach and a good deal of creativity,” Choo, who was not involved in the study, said in an email. “C...
Source: Healthy Living - The Huffington Post - March 28, 2017 Category: Consumer Health News Source Type: news

Explore the Optimal Resolvent of Medical Needs and Mental Health for Patients with Lung Cancer during Epidemic Novel Coronavirus Pneumonia
Conclusions During the emergence of NCP, the medical needs of patients with lung cancer have not been enough, especially those who discontinued chemotherapy or immunotherapy. When medical institution resumes work, priority should be give n to them. At the same time, mental health problems of patients should be valued and resolved timely. DOI: 10.3779/j.issn.1009-3419.2020.101.18
Source: Chinese Journal of Lung Cancer - April 20, 2020 Category: Cancer & Oncology Source Type: research

Evaluation of medical practices in oncology in the context of the COVID ‐19 pandemic in France: Physicians’ point of view: the PRATICOVID study
The PRATICOVID study is the first to assess modification of patient care in cancer outpatients during an epidemic. With this unprecedented crisis, physicians were able to adapt their practice in order to protect their patients against the virus while ensuring continuity of patient care. AbstractThe cancer population seems to be more susceptible to COVID ‐19 infection and have worse outcomes. We had to adapt our medical practice to protect our patients without compromising their cancer prognosis. The national PRATICOVID study aims to describe the adaptation of cancer patient care for this population. We analyzed data from...
Source: Cancer Medicine - October 5, 2020 Category: Cancer & Oncology Authors: Carole Helissey, Anatole Cessot, Laurys Boudin, Emile Romeo, Caroline Prieux, Djamel Ghebriou, Antoine Schernberg, Noemie Grellier, Charlotte Joly, Olivier Bauduceau, Constance Thibault, Elodie Mamou, Gauthier Raynal, Sophie Serey eiffel, He Tags: ORIGINAL RESEARCH Source Type: research

Vaccination for seasonal influenza in patients with cancer: recommendations of the Italian Society of Medical Oncology (AIOM)
Background Influenza virus causes annual epidemics in the winter–spring season with significant morbidity in the general population and important mortality in high-risk groups, including cancer patients. Opinions on the suitability of patients with malignancies not undergoing active treatment and in different phases of antineoplastic therapy, to receive influenza vaccination, vary considerably among oncologists, sometimes even within one center. Methods We reviewed available data, including recommendations by national health authorities, on impact of influenza in patients with cancer and their capacity to mount prot...
Source: Annals of Oncology - May 29, 2014 Category: Cancer & Oncology Authors: Pedrazzoli, P., Baldanti, F., Donatelli, I., Castrucci, M. R., Puglisi, F., Silvestris, N., Cinieri, S. Tags: oncology practice Source Type: research

Expanding Research Capacity in Sub-Saharan Africa Through Informatics, Bioinformatics, and Data Science Training Programs in Mali
Conclusion Bioinformatics and data science training programs in developing countries necessitate incremental and collaborative strategies for their feasible and sustainable development. The progress described here covered decades of collaborative efforts centered on training and research on computationally intensive topics. These efforts laid the groundwork and platforms conducive for hosting a bioinformatics and data science training program in Mali. Training programs are perhaps best facilitated through Africa’s university systems as they are perhaps best positioned to maintain core resources during lapses in sho...
Source: Frontiers in Genetics - April 11, 2019 Category: Genetics & Stem Cells Source Type: research

15 thoughts on eliminating neglected tropical diseases
We summarise the points made by a live chat panel on how the global health community can work towards eliminating NTDsDr Paul Emerson, trachoma control programme director, The Carter Centre, Atlanta, USANTDs aren't as remote or obscure as many think: Trachoma and worms used to be endemic to the US and Europe, but were eliminated through improvements in hygiene, sanitation and access to medical care. NTDs still affect billions of people in the world, so the global NTD conversation needs to focus on how and why NTDs are keeping the bottom billion at the bottom.Build local support by involving community leaders: Involving tru...
Source: Guardian Unlimited Science - May 20, 2013 Category: Science Authors: Anna Scott Tags: Global health Guardian Professional Infectious diseases Pharmaceuticals industry Malaria and infectious diseases Vaccines and immunisation Health policy Editorial Global development professionals network Source Type: news

Conquering Cancer: Personalized Medicine Is the Future
Personalization is threaded into the social fabric of America. Innovation is rooted in customizing and personalizing even the smallest parts of our lives, stemming from technology and retail to travel, media and wellness. The future continues to promise even smarter applications where personalization fits, but what about our health? Enter, precision medicine -- this new era of personalized medicine has arrived to healthcare and the possibilities in treating cancer unimaginable just a few years ago, are closer than ever. Imagine a world where your treatment was tailored to you, taking into consideration every cell and gene ...
Source: Healthy Living - The Huffington Post - June 19, 2015 Category: Consumer Health News Source Type: news

IgG Anti-ghrelin Immune Complexes Are Increased in Rheumatoid Arthritis Patients Under Biologic Therapy and Are Related to Clinical and Metabolic Markers
This study was supported by Instituto de Nutrición y Salud Kellogg's (INSK) by the funding program Apoyo a Proyectos de Investigación en Nutrición (APIN-2016) granted to ZR-C. The funding source had no involvement on the design nor any steps of the study. Conflict of Interest Statement The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. Acknowledgments The authors would like to thank Instituto de Investigación en Ciencias Biomédicas and Centro de Invest...
Source: Frontiers in Endocrinology - April 17, 2019 Category: Endocrinology Source Type: research

ICYMI: Disappearing Amazon Tribes And Why Kids Hate School Lunch
ICYMI Health features what we're reading this week. This week, we were taken with a radio interview featuring Dr. James O'Connell, who spent his 30-year career making "house calls" to Boston's homeless population -- offering them medical care under bridges, in subway tunnels and on the city's streets -- and what he learned from the nurses who served Boston's homeless for years before he joined the team.   We also spent time on a Q&A with rainforest conservationist and ethnobotanist Mark Plotkin, who makes a compelling case for conservation as an ethical exercise, rather than viewing Amazonian species pri...
Source: Healthy Living - The Huffington Post - October 3, 2015 Category: Consumer Health News Source Type: news

Kaposi Sarcoma, a Trifecta of Pathogenic Mechanisms
Diagnostics (Basel). 2022 May 16;12(5):1242. doi: 10.3390/diagnostics12051242.ABSTRACTKaposi's sarcoma is a rare disease with four known variants: classic, epidemic, endemic and iatrogenic (transplant-related), all caused by an oncogenic virus named Human Herpes Virus 8. The viral infection in itself, along with the oncogenic properties of HHV8 and with immune system dysfunction, forms the grounds on which Kaposi's Sarcoma may develop. Infection with HHV8 occurs through saliva via close contacts, blood, blood products, solid organ donation and, rarely, vertical transmission. Chronic inflammation and oncogenesis are promote...
Source: Herpes - May 28, 2022 Category: Infectious Diseases Authors: Gabriela Rusu-Zota Oana M ădălina Manole Cristina Gale ș Elena Porumb-Andrese Otilia Obad ă Cezar Valentin Mocanu Source Type: research

Nucleoside Hydrolase NH 36: A Vital Enzyme for the Leishmania Genus in the Development of T-Cell Epitope Cross-Protective Vaccines
Conclusions Nucleoside hydrolases are vital enzymes for the replication of Leishmania, conserved phylogenetic marker of the genus and strong-specific immunogens. We demonstrated that NH36 is an excellent target for chemotherapy of visceral leishmaniasis. Searching for the most immunogenic fraction of promastigotes of Leishmania we described the FML antigen of L. (L.) donovani, that has as its main component, the NH36 Nucleoside hydrolase. We developed second–generation vaccines with the FML and the NH36 native antigens, and with the NH36 recombinant protein. In addition, we obtained a third generation vaccine base...
Source: Frontiers in Immunology - April 15, 2019 Category: Allergy & Immunology Source Type: research

COVID-19 in Patients with Hematologic Disorders Undergoing Therapy: Perspective of a Large Referral Hematology Center in Rome
Conclusion: In our experience, the prevalence of COVID-19 in hematologic patients, mainly affected by malignancies, was not significantly higher compared to that of the general population. Definition of adapted strategies for healthcare services, while continuing to administer the standard hematologic treatments, represents the crucial challenge for the management of hematologic diseases in the COVID-19 era.Acta Haematol
Source: Acta Haematologica - September 15, 2020 Category: Hematology Source Type: research

COVID-19 in Patients with Hematologic Disorders Undergoing Therapy: Perspective of a Large Referral Hematology Center in Rome.
CONCLUSION: In our experience, the prevalence of COVID-19 in hematologic patients, mainly affected by malignancies, was not significantly higher compared to that of the general population. Definition of adapted strategies for healthcare services, while continuing to administer the standard hematologic treatments, represents the crucial challenge for the management of hematologic diseases in the COVID-19 era. PMID: 32932252 [PubMed - as supplied by publisher]
Source: Acta Haematologica - September 14, 2020 Category: Hematology Authors: Girmenia C, Gentile G, Micozzi A, Petrucci L, Malaspina F, Di Prima A, Baldacci E, Bianchi S, Pugliese P, Turriziani O, Antonelli G, Tombolini V, Foà R, Martelli M Tags: Acta Haematol Source Type: research

Kaposi Sarcoma, a Trifecta of Pathogenic Mechanisms
Diagnostics (Basel). 2022 May 16;12(5):1242. doi: 10.3390/diagnostics12051242.ABSTRACTKaposi's sarcoma is a rare disease with four known variants: classic, epidemic, endemic and iatrogenic (transplant-related), all caused by an oncogenic virus named Human Herpes Virus 8. The viral infection in itself, along with the oncogenic properties of HHV8 and with immune system dysfunction, forms the grounds on which Kaposi's Sarcoma may develop. Infection with HHV8 occurs through saliva via close contacts, blood, blood products, solid organ donation and, rarely, vertical transmission. Chronic inflammation and oncogenesis are promote...
Source: Herpes - May 28, 2022 Category: Infectious Diseases Authors: Gabriela Rusu-Zota Oana M ădălina Manole Cristina Gale ș Elena Porumb-Andrese Otilia Obad ă Cezar Valentin Mocanu Source Type: research